Lab
Hato Rey Pathology Associates INC
Hato Rey Pathology Associates INC was paid $42.02M by Medicaid between Jan 2018 and Dec 2024, across 88 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 27% of everything it billed.
33Billing provider infoHATO REY PATHOLOGY ASSOCIATES INC
SAN JUAN, PR 00918
SAN JUAN, PR 00918
33aNPI1740460583assigned 11/09/2007
33bProvider typeClinical Medical Laboratory
28Total paid$42.02M
24GClaims705,568
24DCodes billed88
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#1 of 777
Median peer was paid$278K
This provider vs. median151×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 53,335 | $2.08M | |
| 2019 | 63,267 | $2.66M | |
| 2020 | 85,875 | $4.03M | |
| 2021 | 105,230 | $5.41M | |
| 2022 | 95,349 | $5.33M | |
| 2023 | 133,592 | $9.03M | |
| 2024incomplete | 168,920 | $13.46M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 27% | 126,283 | 100,126 | $11.46M |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 7.3% | 78,406 | 67,769 | $3.08M |
| 88312 | 7.1% | 24,363 | 19,412 | $2.97M | |
| 88185 | 6.9% | 7,103 | 4,052 | $2.92M | |
| 88307 | 5.4% | 9,640 | 7,816 | $2.28M | |
| 88341 | 5.4% | 6,688 | 5,320 | $2.26M | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.6% | 57,563 | 48,659 | $1.94M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.6% | 57,567 | 48,663 | $1.92M |
| 88142 | 3.9% | 60,112 | 49,588 | $1.63M | |
| 88173 | 2.9% | 8,238 | 6,451 | $1.21M | |
| 88342 | 2.3% | 12,510 | 9,836 | $985K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 2.2% | 37,751 | 34,413 | $911K |
76 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.2% | 18,227 | $908K |
| 88141 | 1.6% | 39,448 | $670K | |
| 10005 | 1.6% | 7,146 | $665K | |
| 88304 | 1.5% | 19,492 | $644K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.3% | 15,507 | $559K |
| 88172 | 1.1% | 7,922 | $476K | |
| 88237 | 1.0% | 5,198 | $431K | |
| 88189 | <1% | 4,489 | $363K | |
| 88313 | <1% | 1,888 | $291K | |
| 88184 | <1% | 5,333 | $257K | |
| 88360 | <1% | 1,516 | $237K | |
| 87536 | <1% | 1,947 | $205K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 4,424 | $195K |
| 88112 | <1% | 4,183 | $192K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 7,529 | $184K |
| 81206 | <1% | 1,343 | $164K | |
| 88302 | <1% | 4,309 | $158K | |
| 88262 | <1% | 923 | $158K | |
| 81513 | <1% | 2,918 | $154K | |
| 87481 | <1% | 3,403 | $105K | |
| 88311 | <1% | 5,330 | $90K | |
| 86360 | <1% | 1,863 | $89K | |
| 87070 | <1% | 7,997 | $83K | |
| 87563 | <1% | 2,894 | $80K | |
| 85097 | <1% | 1,689 | $79K | |
| 87797 | <1% | 3,268 | $78K | |
| 10022 | <1% | 740 | $69K | |
| 88108 | <1% | 1,527 | $64K | |
| 88377 | <1% | 104 | $59K | |
| 88264 | <1% | 716 | $55K | |
| 10006 | <1% | 653 | $49K | |
| 81455 | <1% | 20 | $44K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,199 | $42K |
| 88309 | <1% | 119 | $41K | |
| 88177 | <1% | 1,373 | $40K | |
| 88150 | <1% | 2,950 | $39K | |
| 80061 | Lipid panel | <1% | 2,504 | $37K |
| 81270 | <1% | 578 | $37K | |
| 99201 | <1% | 2,163 | $35K | |
| 80053 | Comprehensive metabolic panel | <1% | 2,931 | $32K |
| 87480 | <1% | 1,661 | $30K | |
| 87510 | <1% | 1,661 | $30K | |
| 87660 | <1% | 1,661 | $30K | |
| 80074 | <1% | 522 | $26K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,728 | $25K |
| 86328 | <1% | 1,212 | $22K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,418 | $21K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 479 | $19K |
| 88300 | <1% | 1,015 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,058 | $11K |
| 81001 | <1% | 1,684 | $6K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,016 | $5K |
| 81207 | <1% | 53 | $5K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 86 | $4K |
| 86777 | <1% | 307 | $4K | |
| 87529 | <1% | 110 | $4K | |
| 87185 | <1% | 694 | $4K | |
| 81338 | <1% | 31 | $4K | |
| 86592 | <1% | 794 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 177 | $4K |
| 81219 | <1% | 34 | $3K | |
| 86738 | <1% | 161 | $3K | |
| 84436 | <1% | 460 | $3K | |
| 84479 | <1% | 425 | $3K | |
| 82150 | <1% | 274 | $2K | |
| 81275 | <1% | 24 | $2K | |
| 83690 | <1% | 278 | $2K | |
| 82607 | <1% | 91 | $1K | |
| 86304 | <1% | 50 | $1K | |
| 88280 | <1% | 156 | $798.83 | |
| 76942 | <1% | 24 | $645.95 | |
| 87186 | <1% | 64 | $433.80 | |
| 88365 | <1% | 14 | $421.62 | |
| 84439 | <1% | 36 | $329.47 | |
| 88291 | <1% | 89 | $322.66 | |
| 87088 | <1% | 34 | $318.47 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVILLARMARZO, GUILLERMO (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Hato Rey Pathology Associates,psc | San Juan, PR | $664K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.